Ginkgo Bioworks Partners with ARPA-H to Advance Oral Therapeutics

Ginkgo Bioworks has partnered with the University of Illinois and ARPA-H to develop new treatments for oral health using its EncapS technology. The collaboration aims to leverage Ginkgo's advanced microbial screening capabilities and expand its role in translational research for oral therapeutics. This partnership may influence Ginkgo's investment narrative and growth outlook, but the company's short-term challenge remains generating sustainable top-line growth.